Serum aspartate aminotransferase, a novel potential biomarker of prognosis in extranodal natural killer/T cell lymphoma, nasal type
Cancer Biomarkers · 2024
DOI: 10.3233/cbm-230068 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Biomarkers, 2024. Verfasst von Ningning Yao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Canc…. Hauptthemen laut MEDLINE: Lymphoma, Extranodal NK-T-Cell, Aspartate Aminotransferases, Biomarkers, Tumor. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Aspartate aminotransferase (AST), an indicator of liver cell damage, was related to the prognosis of certain malignant tumors. OBJECTIVE: This study examined the predictive value of AST in patients with extranodal natural killer/T cell lymphoma (ENKTL). METHODS: We reviewed 183 cases diagnosed with ENKTL and selected 26 U/L as the optimum cut-off value of AST. We used the univariate and multivariate Cox regression to compare the different AST groups’ overall survival (OS) and progression-free survival (PFS). RESULTS: Prior to propensity score matching (PSM), Kaplan-Meier analysis showed that patients in the low AST subgroup had better OS and PFS than the high AST subgroup. Multivariate analysis revealed that AST was an independent indicator for prognosis. After PSM, the low AST subgroup maintained a significantly better OS and PFS than the high AST subgroup. CONCLUSION: AST might represent a significant prognostic marker for ENKTL patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiotherapy, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi,…
- Department of Tumor Biobank, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi,…
Zitieren
APA
Yao, N., Hou, Q., Liang, Y., Cao, X., Sun, B., Wei, L., Sun, R., & Cao, J. (2024). Serum aspartate aminotransferase, a novel potential biomarker of prognosis in extranodal natural killer/T cell lymphoma, nasal type. Cancer Biomarkers. https://doi.org/10.3233/cbm-230068
Vancouver
Yao N, Hou Q, Liang Y, Cao X, Sun B, Wei L, et al. Serum aspartate aminotransferase, a novel potential biomarker of prognosis in extranodal natural killer/T cell lymphoma, nasal type. Cancer Biomarkers. 2024. doi:10.3233/cbm-230068
BibTeX
@article{Yao2024,
author = {Yao, Ningning and Hou, Qing and Liang, Yu and Cao, Xin and Sun, Bochen and Wei, Lijuan and Sun, Ruifang and Cao, Jianzhong},
title = {Serum aspartate aminotransferase, a novel potential biomarker of prognosis in extranodal natural killer/T cell lymphoma, nasal type},
journal = {Cancer Biomarkers},
year = {2024},
doi = {10.3233/cbm-230068}
}
EUVIMED